Perbedaan Organon Pharma Indonesia Tbk. dan Trias Sentosa Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Trias Sentosa Tbk. diperdagangkan di Rp462 (kapitalisasi pasar 1,3 T, volume 24 jam 65,4 rb). Perbedaan utamanya: Trias Sentosa Tbk. jauh lebih besar — sekitar 12,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | TRST | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,3 T |
Volume | — | 65,4 rb |
Lot | — | 654 |
Perputaran | — | 30,18 jt |
Harga Rata-rata | — | 461,54 |
Nilai Transaksi | — | 30,18 jt |
Harga Ekuilibrium Indikatif | — | 462 |
Volume Ekuilibrium Indikatif | — | 435 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Trias Sentosa Tbk was established on November 23, 1979 and started commercial operation in 1984 with total capacity of 4.500 tons BOPP (biaxially oriented polypropylene) film per annum. In 1989, the Company completed expansion of its second line BOPP film with capacity of 7.500 tons per annum. In 1993, the Company completed its expansion of third line BOPP film with capacity of 12.000 tons per annum, and in 1995, Polyester film project with total capacity of 12.000 tons were completed. In 1996, the Company completed its expansion of fourth line BOPP film with total capacity of 16.000 tons. Currently, the Company is the largest BOPP Film and Polyester Film producer in Indonesia.
Selengkapnya di halaman TRST →